Literature DB >> 6141997

Subcellular localization of enzymes involved in leukotriene formation within human polymorphonuclear granulocytes.

J Brom, M Raulf, M Stüning, B Spur, A Crea, K D Bremm, W König.   

Abstract

The subcellular localization of enzymes involved in leukotriene formation was analysed according to biological (chemotaxis, spasmogenic properties) and analytical methods. By subcellular fractionation the major activity for 5--lipoxygenase and L-gamma-glutamyltranspeptidase coeluted with the 200,000 g precipitate while glutathione-S-transferase activity was mainly present in the 200,000 g supernatant. Our data were supported by results indicating that the 200,000 g precipitate and supernatant fractions proved to be most active in generating 5-HETE and leukotriene C4 (LTC4) respectively. The 200,000 g pellet was the most active fraction in transforming synthetic LTC4 into LTD4 and LTE4. When synthetic LTD4 was incubated with the various subcellular fractions and the appearance of LTE4 was analysed the 20,000 and 200,000 g pellets were the most potent fractions. Several discrepancies observed using biological, biochemical and analytical (synthetic substrates) methods may be in part due to the formation of leukotriene isomers which interfere with the biological assays.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6141997      PMCID: PMC1454457     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  43 in total

1.  Release of eosinophil chemotactic factor from human polymorphonuclear neutrophils by calcium ionophore A23187 and phagocytosis.

Authors:  B M Gzarnetzki; W Konig; L M Lichtenstein
Journal:  Nature       Date:  1975-12-25       Impact factor: 49.962

2.  Eosinophil chemotactic factor (ECF). II. Release from human polymorphonuclear leukocytes during phagocytosis.

Authors:  W König; B M Czarnetzki; L M Lichtenstein
Journal:  J Immunol       Date:  1976-07       Impact factor: 5.422

3.  Generation and release of eosinophil chemotactic factor from human polymorphonuclear neutrophils by arachidonic acid.

Authors:  W König; H Tesch; N Frickhofen
Journal:  Eur J Immunol       Date:  1978-06       Impact factor: 5.532

Review 4.  The glutathione S-transferases: a group of multifunctional detoxification proteins.

Authors:  W B Jakoby
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1978

5.  Generation and secretion of eosinophilotactic activity from human polymorphonuclear neutrophils by various mechanisms of cell activation.

Authors:  W König; N Frickhofen; H Tesch
Journal:  Immunology       Date:  1979-04       Impact factor: 7.397

6.  Glutathione S-transferases. The first enzymatic step in mercapturic acid formation.

Authors:  W H Habig; M J Pabst; W B Jakoby
Journal:  J Biol Chem       Date:  1974-11-25       Impact factor: 5.157

7.  A particulate arachidonate lipoxygenase in human blood platelets.

Authors:  P P Ho; C P Walters; H R Sullivan
Journal:  Biochem Biophys Res Commun       Date:  1976-05-23       Impact factor: 3.575

8.  Arachidonate lipoxygenase in blood platelets.

Authors:  D H Nugteren
Journal:  Biochim Biophys Acta       Date:  1975-02-20

9.  Transformation of arachidonic acid by rabbit polymorphonuclear leukocytes. Formation of a novel dihydroxyeicosatetraenoic acid.

Authors:  P Borgeat; B Samuelsson
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

10.  Biochemical and morphological characterization of azurophil and specific granules of human neutrophilic polymorphonuclear leukocytes.

Authors:  U Bretz; M Baggiolini
Journal:  J Cell Biol       Date:  1974-10       Impact factor: 10.539

View more
  10 in total

1.  Metabolism of leukotrienes by L-gamma-glutamyl-transpeptidase and dipeptidase from human polymorphonuclear granulocytes.

Authors:  M Raulf; M Stüning; W König
Journal:  Immunology       Date:  1985-05       Impact factor: 7.397

2.  [Significance of leukotrienes in chronic respiratory tract diseases in childhood].

Authors:  W Schönfeld; M Köller; J Knöller; W Müller; H vd Hardt; W König
Journal:  Klin Wochenschr       Date:  1986-03-17

3.  Sulfidopeptide-leukotriene peptidases in pulmonary edema fluid from patients with the adult respiratory distress syndrome.

Authors:  W D Ratnoff; M A Matthay; M Y Wong; Y Ito; K H Vu; J Wiener-Kronish; E J Goetzl
Journal:  J Clin Immunol       Date:  1988-07       Impact factor: 8.317

4.  Effect of thiol-activated toxins (streptolysin O, alveolysin, and theta toxin) on the generation of leukotrienes and leukotriene-inducing and -metabolizing enzymes from human polymorphonuclear granulocytes.

Authors:  K D Bremm; W König; P Pfeiffer; I Rauschen; K Theobald; M Thelestam; J E Alouf
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

5.  Effect of cations on leukotriene release: requirements for the metabolism of peptido-leukotrienes (leukotrienes C4, D4) by human polymorphonuclear granulocytes.

Authors:  M Raulf; M Stüning; W König
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

6.  Leukotriene generation and metabolism in isolated human lung macrophages.

Authors:  W Schönfeld; B Schlüter; R Hilger; W König
Journal:  Immunology       Date:  1988-12       Impact factor: 7.397

7.  Generation of slow-reacting substance (leukotrienes) by endotoxin and lipid A from human polymorphonuclear granulocytes.

Authors:  K D Bremm; W König; B Spur; A Crea; C Galanos
Journal:  Immunology       Date:  1984-10       Impact factor: 7.397

8.  Leukotriene biosynthesis inhibitors.

Authors:  J R Cashman
Journal:  Pharm Res       Date:  1985-11       Impact factor: 4.200

9.  Contribution by polymorphonucleate granulocytes to elevated gamma-glutamyltransferase in cystic fibrosis sputum.

Authors:  Alessandro Corti; Maria Franzini; Silvana Cianchetti; Gabriella Bergamini; Evelina Lorenzini; Paola Melotti; Aldo Paolicchi; Pierluigi Paggiaro; Alfonso Pompella
Journal:  PLoS One       Date:  2012-04-04       Impact factor: 3.240

10.  Diabetic and non-diabetic human cornea and tear γ-glutamyl transpeptidase activity.

Authors:  Jordan M Burnham; Monali Sakhalkar; Marlyn P Langford; Chanping Liang; Thomas B Redens; Sushil K Jain
Journal:  Clin Ophthalmol       Date:  2013-01-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.